Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

AR cooperates with SMAD4 to maintain skeletal muscle homeostasis.

Journal article

Forouhan M. et al, (2022), Acta Neuropathol

Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model

Journal article

Overby SJ. et al, (2022), Molecular Therapy - Nucleic Acids, 27, 1146 - 1155

Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.

Journal article

Kandasamy P. et al, (2022), Nucleic Acids Res

Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology

Chapter

Martin Perez C. et al, (2022), Methods in Molecular Biology, 2383, 119 - 141

Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy.

Journal article

Cerro-Herreros E. et al, (2021), Mol Ther Nucleic Acids, 26, 174 - 191

Dystrophin involvement in peripheral circadian SRF signalling.

Journal article

Betts CA. et al, (2021), Life Sci Alliance, 4

Extracellular vesicles as a next-generation drug delivery platform

Journal article

WOOD M. et al, (2021), Nature Nanotechnology

Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases.

Journal article

Aoki Y. and Wood MJA., (2021), J Neuromuscul Dis

Improving assessments of data-limited populations using life-history theory

Journal article

Horswill C. et al, (2021), Journal of Applied Ecology, 58, 1225 - 1236

Load More